Publication Name	World Journal of Gastroenterology
Manuscript ID	32140
Country	Japan

Received	2016-12-27 11:20
Peer-Review Started	2016-12-27 21:18
To Make the First Decision	2017-02-10 08:44
Return for Revision	2017-02-13 13:23
Revised	2017-02-21 18:14
Second Decision	2017-03-17 18:07
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2017-03-21 11:12
Articles in Press	2017-03-21 11:12
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2017-04-11 20:26
Publish the Manuscript Online	2017-04-20 15:58

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Surgery
Manuscript Type	Retrospective Cohort Study
Article Title	Optimal treatment for Siewert type Ⅱ and Ⅲ adenocarcinoma of the esophagogastric junction: A retrospective cohort study with long-term follow-up
Manuscript Source	Invited Manuscript
All Author List	Kei Hosoda, Keishi Yamashita, Hiromitsu Moriya, Hiroaki Mieno and Masahiko Watanabe
Funding Agency and Grant Number
Corresponding Author	Kei Hosoda, MD, PhD, Department of Surgery, Kitasato University, Kitasato 1-15-1, Minami-ku, Sagamihara, Kanagawa, 252-0374, Japan. k.hosoda@kitasato-u.ac.jp
Key Words	Adenocarcinoma of the esophagogastric junction; Lymph node ratio; Venous invasion; Lymph node dissection; Prognostic factor
Core Tip	We reviewed the medical records of 83 patients with Siewert type Ⅱ and Ⅲ adenocarcinoma of the esophagogastric junction. The median duration of observation was 73 mo. Lymph nodes along the lesser curvature, right and left paracardial lymph nodes, and lymph nodes along the left gastric artery should be dissected in patients with Siewert type Ⅱ or Ⅲ adenocarcinoma of the esophagogastric junction. Patients with vigorous venous invasion and lymph node ratio of > 0.16 should be treated with aggressive adjuvant chemotherapy to improve survival outcomes.
Publish Date	2017-04-20 15:58
Citation	Hosoda K, Yamashita K, Moriya H, Mieno H, Watanabe M. Optimal treatment for Siewert type Ⅱ and Ⅲ adenocarcinoma of the esophagogastric junction: A retrospective cohort study with long-term follow-up. World J Gastroenterol 2017; 23(15): 2723-2730
URL	http://www.wjgnet.com/1007-9327/full/v23/i15/2723.htm
DOI	http://dx.doi.org/10.3748/wjg.v23.i15.2723

Full Article (PDF)	WJG-23-2723.pdf
Full Article (Word)	WJG-23-2723.doc
Manuscript File	32140-Review.docx
Answering Reviewers	32140-Answering reviewers.pdf
Audio Core Tip	32140-Audio core tip.mp3
Biostatistics Review Certificate	32140-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form	32140-Conflict-of-interest statement.pdf
Copyright License Agreement	32140-Copyright assignment.pdf
Signed Informed Consent Form(s) or Document(s)	Informed_Consent_Statement_20161226194513.docx
Institutional Review Board Approval Form or Document	32140-Institutional review board statement.pdf
Non-Native Speakers of English Editing Certificate	32140-Language certificate.pdf
Peer-review Report	32140-Peer-review(s).pdf
Scientific Misconduct Check	32140-Scientific misconduct check.pdf
Scientific Editor Work List	32140-Scientific editor work list.pdf